Serum Otoconin-90 and Otolin-1 Concentrations in Benign Paroxysmal Positional Vertigo
Biomolecules · 2024
DOI: 10.3390/biom14101279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Demet Aygun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey. Hauptthemen laut MEDLINE: Benign Paroxysmal Positional Vertigo. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The aim was to evaluate the value of otolith-associated protein otoconin-90 (OC90) and otolin-1 in the pathogenesis research and clinical treatment of benign paroxysmal positional vertigo (BPPV). Material and Method: The study included 50 patients with BPPV admitted to neurology and otorhinolaryngology departments and 30 healthy subjects with no history of dizziness as a control group.
Results
BPPV and controls were similar in terms of gender and age. Otolin-1 concentration was significantly greater in the BPPV group than in the controls (710.44 [584.35–837.39] vs 280.45 [212.7–419.61]; p < 0.001). No statistical significance was found, although OC90 was higher in the BPPV group than in the controls. There was a strong positive correlation between otolin-1 and OC90, a moderate negative correlation between otolin-1 and vitamin D, and a strong negative correlation between OC90 and vitamin D in the BPPV patient group. Otolin-1 had high specificity and AUC values for BPPV (AUC: 0.933; 95% CI: 0.881–0.986, 79.2% sensitivity, 100% specificity with a cutoff greater than 525).
Conclusions
High serum concentrations of otolin-1 were associated with an increased risk of BPPV, but high concentrations of OC90 were not. Serum concentrations of otolin-1 can potentially be used as a biomarker for the acute onset of inner ear disorders due to the significant increase in patients with BPPV. Vitamin D has high specificity and sensitivity in patients with BPPV. It also provides evidence that BPPV patients with vitamin D deficiency may improve their symptoms with replacement therapy. More large-scale prospective studies are required to confirm these associations and clarify the exact mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey.
- Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey.
- Department of Otorhinolaryngology, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey.
ORCID-Profile: Demet Aygun, Seyma Dumur, Hafize Uzun
Zitieren
APA
Aygun, D., Dumur, S., Elgormus, M. N., Alpaslan, M. S., & Uzun, H. (2024). Serum Otoconin-90 and Otolin-1 Concentrations in Benign Paroxysmal Positional Vertigo. Biomolecules. https://doi.org/10.3390/biom14101279
Vancouver
Aygun D, Dumur S, Elgormus MN, Alpaslan MS, Uzun H. Serum Otoconin-90 and Otolin-1 Concentrations in Benign Paroxysmal Positional Vertigo. Biomolecules. 2024. doi:10.3390/biom14101279
BibTeX
@article{Aygun2024,
author = {Aygun, Demet and Dumur, Seyma and Elgormus, Mehmet Nuri and Alpaslan, Mehmet Serkan and Uzun, Hafize},
title = {Serum Otoconin-90 and Otolin-1 Concentrations in Benign Paroxysmal Positional Vertigo},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14101279}
}
EUVIMED